The head of the Oxford Vaccine Group said Friday that clinic trials on its vaccine for the coronavirus are"progressing very well."
Oxford University has an exclusive deal with the company Oxford Sciences Innovation to commercialise all its research - and a SA fund manager is the largest shareholder in OSI.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut: